ITEM No. 24 FILE No. X—14 and XII—23 COPY No.. THE NX ORGANON PHARMACEUTICAL FACTORY COMBINED INTELLIGENCE OBJECTIVES SUB-COMMITTEE THE N. V. ORGANON'PHARMACEUTICAL FACTORY OSS, HOLLAND Report by Lt. Colonel H. J. PH2LPS CIOS Black List Item 24 Medical COMBINED INTELLIGENCE OBJECTIVES"SUB COMMITTEE G-2 DIVISION, SHASF le 1. Requirements for Restarting of Production APPENDIX I. SCIENTIFIC AND TECHNICAL DEVELOPMENTS IN THE PREPARATION OF SYNTHETIC HORMONES Oxidation of Cholesterol: The oxidation of cholesterol-acetate dlbromide is at present carried out in a homogeneous mixture of acetic acid and ethylenedlchlorlde. The result of this new procedure is a 50% Increased yield. This method is applied now by Ciba (Basle), Sobering (Berlin) and Organon. Desoxycorticosterone-acetate: The preparation of diazomethane is now possible on a relatively large scale, and in consequence it is possible to prepare desoxycorticosterone-acetate on a technical scale. There are no fundamental changes from the original Reichsteln procedure for the synthesis. Progesterone: As the new oxidation-process of cholesterol (see above) gives no pregnenolone-acetate, it was necessary to look out for a new preparation method for this substance. In the Sobering works the procedure (which has been published by Butenandt c.s. in Berlchte) has started on a technical scale. With this method it is possible to reach a ZZ% yield of progesterone from Dehydro androsterone- acetate. Ethinyl-testosterone; ifi'e preparation of ethlnyl-androstenediol is now possible with other alcohols than tertiary butanol. Synthetic Oestrone: It was very Important for Sobering to prepare oestrone from another source than pregnant mares1 urine. The chemists of Sobering, especially Inhdffen, have.carried out the synthesis of oestrone starting from dehydro androsterone-acetate and as far as we know this procedure has been applied on a technical scale, (published in Berichte by Inhoffen), The most difficult stage is the dehydrogenating and demethylatlng of the first ring. Following the data received from the German chemists the total yield is between 10 and 20%• As far as is known the whole procedure is not yet carried out regularly in the factory. APPENDIX II. PERISTON This substitute for blood liouid was prepared by Weese and Hecht (pharmacological institute of the I. CL Farben), described in the publication : Hecht und Weese “Periston, ein neuer Blutflueslgkeitersatzn (Munch, med. Wschr. 90, 11 (1943) No.l. It consists of a colloid, the polymerisation pro- duct polyvinylpyrrolldon (known as’ "Kollldon") In a 2..$% solution, to'which Is added' NaCl, 0,9042^ KOI, CaClo, 0,0005;* MgClg, 0,0024# NaHC03“ and ca. 10 vol. % free COo. This solution has a pH 6, and after being steritlzed is ready for use and keeps indefinitely. Tills product and similar mixtures of slightly different composition are described collective- ly as "Periston". In the animal it.normalizes the blood pressure after an acute loss of blood. Its action persists for one or two days; after three to four weeks the substance can no longer be detected in the blood. H Clinical experiences were published by Klees (Munch.Med. Wschr. 90, 29 (1943) No.2* According to this author Periston is superior to all other known plasma substitutes. He tested it in 50 oases of haemorrhage w mostly severe - (laparotomies, various obstetrical cases); the doses varied from 100 to 700 cm3. He observed a prompt restoration of normal blood pressure without noxious Influences. The main actions ares- (1) An analeptic action; (2) A vasotonic action; (3) An improvement of the capillary circulation. Dieckhoff and Kunstler (Dtsch.Med.Wschr. 69, 589 (1943) No.33/34, obtained favourable results wltHPerlston in alimentary intoxication of sucklings. Fonio "Blutersatz im Felde" (Sitz.ber.medlz.Bezlrksver- ein,' Bern-Stadt, Schweiz.med. Wschr. 73, 1416 (1943) No.47, remarks, concerning|f"das an der Ostfront verwend- ete Periston": "Die Akten uber die desselben sind noch nicht |(abgeschlossen; Armeepathologen machen auf Leber—Nlerensohadigungen aufmerksam". The last work has not yet been said about its action; German army pathologists have called attention to liver and kidney damage. APPENDIX III. APPLICATION OF CAPAIN IN SHOCK, Literature: L. A. Gr. Hisslnk, Ned. TIJdschr. v. G-eneesk. 38, 52l (1944); 88, 824 (1944). J. H. P. Jonxis. Maandschr. Kindergew. 13, 169 (1944) Capaln is an aoueous solution of the breakdown products of casein, obtained by the action of papain on this protein. It is characterised by its high colloid©smotic pressure and its freedom from anaphy- lactogenic properties. It serves to retain fluid in the blood streaA and also provides readily assimil- able nitrogen to the body. It has been Issued for clinical purposes in 100 cc. ampoules filled with a 15% solution of the combination of these peptones and polypeptides. A special type of capain is prepared for intrave- nous nitrogen feeding especially *for infants. The source of protein in this case consists of two parts of casein and one part of lactalbumen, to supply the necessary amount of tryptophane and cystein. Method of Application: The usual dose of capain is from 75 to 150 cc. diluted with physiological saline, or 5% glucose solu- tion to 1 L. It is Injected intravenously, the rate of the injection depending on the condition of the patient. In cases of shock, blood pressure is chosen as the criterion, severe cases demanding a faster rate amounting up to 1 L per hour. Results. A review is given of twenty cases of more or less severe shock. The results of the treatment were satis- factory; only three of the patients died in the first week after the transfusion. Five of the patients had a slight general reaction (shivers). With another twenty patients the author claims to have obtained similar favourable results, but no details are given. APPENDIX III (Continued) Jonxis claims favourable results In Infant feeding by the intravenous route* It is well tolerated and he gains the impression that capaln Is a complete protein substitute. Method of Preparation The following prescription is based on infor- mation obtained from Professor Brinkman of Groningen, who is the Inventor of capaln, and on limited experience in the Organon factory. 180 grs of sodium caseinate (soluble) are dissolved in 900 cc. of cold water. To this solution is added a buffer solution of the composition: 40 vol. of citric acid 21 gr/I. 60 vo'l. oBaikaline sodium phosphate (NagHP04 2 aa) 35,6 gr/1. To this mixture 900 cc. of boiling water and finally 12 gr of papain (l : 80) are added. The cloudy solution is stipred for ten hours at a temperature of 60 to 70° C. The initial pH of the salution is approximately 5.8. During the digestion much of the casein dissolves but the cloudiness does not disappear completely. The solution is left overnight and a precipitate of undigested material settles to the bottom. It is decanted or filtered. To the filtrate trichloro- acetic-acid is added to a final concentration of 3 g/100 cc. The precipitate is filtered off through folded filters and the clear filtrate neutralised with 25# NaOH until Just red to Congo red. At this acidity the trlchlore-aoetlc-acid is transformed into chloroform and sodium carbonate, provided the temperature 1b not too low. It is found advantageous to keep the solution at 60 to 70° C to promote the reaction. In case the solution becomes alkaline it is neutralised by means of citric acid. The solution is then concentrated in vacuo to one- third of its original volume. The temperature in the original recipe was not specified but apparently 60 to 70° C will do. At the end of the process the tempera- ture is raised to boiling point for a few minutes* Finally the solution is kept for two to three days at room temperature. A slight precipitate which occasion- ally forms is filtered off through asbestos fibre or hyflo filters. APPENDIX III (Continued) The nitrogen content of the filtrate Is estimated. The strength of the solution Is. calculated by taking 8 x the N-content. It is adjusted to 13 to calculated back to protein. As a preservative 270 nlpagln (p-oxy-benzolcacld methylester) is added. It is Issued in 100 cc. ampoules. Before use these ampoules must be carefully cleaned, preferably by bichromate-sulphuric acid solution, follov/ed by frequent washings with water. The last rinse should always be one of freshly distilled apyrogenlc water. The filled ampoules are sterilized for one hour by live steam. Samples of the ampoules ready for issue are subjected to a sterility test. The toxicity in test animals is quite low; 5 cc' are well tolerated if slowly injected in the marginal earveln of a rabbit. No anaphylactic reactions are apparent in appropriate test on guinea pigs. Organon have so far,prepared two batches only and the definite tests for. the toxicity have not yet been established. Meanwhile the above-mentioned tests are used provisionally. Care should be taken to avoid the development of micro-organisms during any stage of the process as subsequent sterilisation would still leave dead bacterlas in the solution liable to cause pyrogenic reactions. APPENDIX IV. VITAMIN C. The shortage of vitamin C in German occupied territory and the impossibility of importing sufficient ouantlties, made it desirable to manu- facture vitamin C in Holland. As Hoffmann-1a-Roche were unwilling to grant a licence a new process was evolved. This starts from glucose and uses the classical steps sorbitol - sorbose - ketogulonic acid. It avoids the use of potassium-permanganate and of large cuantities of acetone, both substances having been very scarce in German-occupied countries. As an oxidizing agent sodium-chlorate is used. The conversion of sodlum-ketogulonate to ascorbic acid is performed with the aid of sodium fluoride. The whole process falls.cut side the scope of the Swiss patents, although this is still being contested by Hoffman-la-Hoche. The yields of ascorbic acid are considerably inferior to those obtained by the Swiss process. The Dutch Government has stimulated research through an official organisation and they too have found a new process ("which, to our mind, is partly dependent on the Swiss patents").# Large scale production has also been taken up following this "Government- process ". * Dr. Tauskfs comment. APPENDIX V. VITAMIN A. In the course of experiments on a synthesis of Vitamin A the ketone I was prepared. From this sub- stance 1:.he methyl-ester of Vitamin A-acld II Is ob- tained by means of methyl-bromo-acetate and zinc in benzene. This acid possessed about one-tenth of the biological activity of vitamin A itself. The prospects for the preparation of Vitamin A from I, are good. As ester of the iso-vitamin A acid II was also prepared. This substance was not active. ch3 ch3 ch3 0% X" GH « CH - C - CH - CH - CH - 0 » 0 ®c„3 3 I ch3 ch3 CH « CH - C s CH - CH - CH - C « CH - COOH II CHg CH3 jj - GH » CH - C = GH - C s GH - CH = CH - -COOK III APPENDIX VI. HARFANIL HgN-HgO-OaOoNHg Kg.rfg.nil (originally named Hesudln) was synthesized by Klarer. On the basis of experiments with animals It was recommended by Domagk for the clinical treat-, ment of infections by anaerobic bacteria (e,g, gas- gangrene). In.the'animal the toleration is excellent. (Domap’k und Hegler. ‘'Chenotheraple bakterieller InfektlonenH 2. Aufl., Leipslz 1942). According to Hegler there is as yet (1942) little experience concerning the application In man. However, several Investigators have recommended the preparation, amongst others Konjetzny. who used a combination with sulphanilanide (Prontalbin) locally against wound Infection. This combination Marfan11- Prontalbln (l part M, 9 parts P) is supposed to be active both against streptococci (and staphylococci) and anaeroblcs. The first publication concerning this combination Is probably that by Beyer MDle Chemotheraple In der Hand des Chirurgent Marfanll- Prontalbln, eln neues WundantlseptikumH (Zbl.Chir. 68. 1730, 1941; not available In Oss). Other References it Meull. HZur Frage der Fruhbehandlung von Kriegsver- let zungen mlt Sulfonamiden M. (Schweiz.med. Wschr. 74, 23, 1944). M. mentions that Klages (Med.Klin*1943. 37/38) saw good results in war wounds with Marfanil for the treatment and prophylaxis of gasgangrene. It is stated further that the combination Marfanll- Prontalbln has been recommended for war wounds by Domagk. Haferland. Konietzny and others (in local and oral application). Kirschner is sceptic about the benefit of M.P. In the treatment of wounds. Florcken stresses the harmlessness of large doses of U.P. powder, locally applied. G. Herrmannf Marfan 11-Prontaiblnpuder In der'Krleg- lchirurgle (Munch. medfWschr. 90, 697 (1943), No. 48/49). H. reports on his experiences with the German army in Russia. He used the preparation for many different injuries. According to this author the locally,applied M.P. powder gives a chance of success in fresh wounds only (up to 12 hours after the injury)1 As to fresh wounds, H. advocates universal application of M.P. powder (after primary wound excision). APPENDIX VI. (continued) H. W. Voigt ( SulphpnamIdes in surgery). (Dtsch.med. 'Ws ;hr. 70, 93 (1944) No. 7/8). V. used, among other preparations, II.P. powder locally with very favour- able results. H, Kr ue H Sulpho n am id e an der Front." (Dtsch.med. Wschr. 69, 417 (1943) No.2l/?2. K. saw good effects of sulpHpnpmides (locally and orally) in the treat- ment of war wounds. He also mentions casually the use of M. P. Eunike. "Uber die lokale Anwendung (Jes Mar fan 11- Prontalbin in der ChlrJLrgle zur Bekampfung der Wund- infektion". Fortsohrltte der Theraple 18, 11 (1942) (not available in Oss). Preparation of Marfanil:- Formula HgM-HoG-< > 30,11 Ho German Patent 7P.6336 (priority 27.1.39): Protection for the reaction RCHg< >30oNHp—>NHp CH2S02NH2, executed in practically every Imaginable way. (R* a substituent which can be converted to the amino group). Included is also the reduction of / %C- S02NH2. rman Patent Application I 67614 (priority 8.8.40): Halogenation of compounds with the formula CH3 S02Hlg (HLg ss halogen) with halogenatlng agents at Increased temperatures. German Patent Application I 67629 (priority 8.8.40); Reaction of compounds with the formula SOoHlg (as produced by the preceding patent application) with ammonia at temperature below 60°C, thus producing HlgCHo S°2NH2 TIP AT IN (l.G. Farben). Formula 0 gHio CC«N- < > S0o-- Ng Cg H-| oQ 5 (digalactoside of dlaralnodiphenvl sulfone) No particulars about the preparation available. APPENDIX VI (Continued) German Patent 694679 (priority 21.10.38): Preparation of stable solutions of compounds like Tlbatln, by addition of sugars to the solu- tion. In an example the addition of Inverted lactose to a solution of Tibatin is mentioned. APPENDIX VII DOLANTIN. Chlorhydrate of l-methyl-4-phenylplperldln-4-carbon- icacld-ethyl-ester. Tabl. 25 mg, amp. 100 mg. No information was available at Organon regard- ing the manufacture of Dolantin. The following references to its use had been filed in the Organon scientific library Schlungbaum (lied.Klin. 35, 1259, 1939). Dolantin opuses no addiction, no habituation. Skamnakis (Zbl.Gynak. 67, 139.7, 1943). Dolantin is frequently used in obstetrics as an analgesic. The author has recently replaced Dolantin by the "Analgetlcum 446” bayer, the latter having a better spasmolytic and analgesic action (no details on the latter.preparation).> v* Brucke (Wien.kiln. Wschr. 1940 II, 854; ref Klin* Wsohr. 22, 59, 1941). Dolantin gives rise to addiction in predisposed individuals; therefore one has to be cautious in prescribing this preparation. Kucher. MZwei Falle von Dolantinsucht* (Klin.Wschr. 19, 688, 1940). Describes two cases of pronounced addiction (high dosos; up to 25 amp. s 2,5 g pro die.1). This should be a warning, as most clinicians deny that there can be such a thing as addiction to Dolantin. The author emphasizes, the Importance of this “ersatz” for morphine, the necessary raw material being available in.Germany. G-ar ratal et al. (ref. Schweiz, med* Wschr. 73, 83,1943). Prolonged use of Dolantin leads to habituation. Oelkers and Wanowius (Klin. Wschr. 21, 752, 1942) demon- strated in micean increase of'toxicity of various substances, among which Dolantln, when the animals were treated with eulphonanldes. This might be important for therapeutics in man. APPENDIX VIII SESAROL. H CCI3 The drug Is a poison for all kinds of Insects# It works by simply contact with the animal. It Is scarcely soluble In water but to a large extent In lip- old solvents. Therefore, It Is easily absorbed by the lip- oids in the cutlcula of Insects. It reaches the nerve endings and because it Is a typical nerve poison kills the animals under violent spasms. The skin of mammals is not permeable for G-esarol, therefore no toxic effects are to be expected In these animals. Because contact with the skin is necessary, G-esarol is more active against flies, mosquitos, moths, etc# than against hairy animals like caterpillars. best be applied by making a solution, e.g. in‘carbontetrachlorlde, and spraying this on the walls of the room, on the floor, on leaves of plants, etc. Very small amounts suffice, a stable could be kept free from flies for five to six we3kg with an amount of five to seven g pro cm2. To kill a rat of about 60 grams an amount of 25 mg given orally is necessary, mice of about 20 grams body weight can be killed with 20 mg. The effect is not immediate, a lag time (for resorption) is present, depending on the species of animal. A good survey of G-esarol and related drugs can be found in Helv.chlm.acta. £7, 892, (1944). APPENDIX IX PENICILLIN The Organon specialists knew nothing of any large scale manufacture of penicillin in Germany. It will of course be known in England, that Clba of Bale has taken up the manufacture of this prod- uct. Reports were published in a special issue of the Schweiz. Med. Wschr. 74, No.23, (1944). From private information they know that Sobering were engaged on rather Intensive research on penicillin. On various occasions they obtained strains of penicillium notatum from Professor Westerdijk of Baarn, who is in charge of the HCen- traal Bureau voor Schimmelcultures H, having at its disposal what is probably the largest collection of moulds of the world. From discussions with Professor Westerdijk the impression was gathered that the strains of penicillium notatum, available in Holland and delivered to Sobering, were probably Inactive as regards penicillin-formation. It is understood that the fluid of their cultures is blue. On the other hand Professor Julius, collab- orating with Dr. Tausk of Organon and with Professor Westerdijk, took up penicillin research secretly. Unis has never been brought to the notice of the German wartime managers of Organon, A strain of moulds was found, giving a high yield of a very active anti-bacterial substance. It cannot yet be said whether this is identical with penicillin, al- though in many respects it behaved exactly like it. Other Dutch centres of research have recently become actively interested in penicillin and other anti-bacterial substances of moulds. It is believed that none has got so far as Professor Julius and his collaborators. APPENDIX X. 1st of Shortages (alphabetically arranged) Acetic Acid; Delivery almost stopped after the Amsterdam factory had been damaged. In 1944 we received three tank loads from Germany. Acetone: First years, of the war almost unobtainable. Later on a spe- cial permit. Acetylsalicylic Acid: Limited import from Germany In bulk. Ethyl Alcohol: Though rather scarce always obtainable. Aneurlne; Irregular though sufficient deliveries from Germany and Hungary. Asbestos Filters: (Seitz). Almost unobtainable. Benzaldehyde; Sporadic supplies. Boron Compounds unobtainable. The last batches of ampoules received from Germany were of boronfree glass of very poor ouality. Chinydron; Very difficult. Chromium salts nad to be handed. In exchange( I. G.) • Chloroform; Very limited. Chloro-suLohonlc Ac Id: Obtainable though restricted. Chromic Acid; Very short. Code In: Not available. Cod liver oil; Unobtainable. Coffeine and its salts: Mot available In.Germany. Small stocks in Holland. Germans attempted a synthesis. APPENDIX X (Continued) Dlchloro-ethylene; In Holland unobtainable. X. G, Farben delivered small Quantities but Informed us Just before the liberation that they were unable to continue. Dimethylsulphate; Unobtainable, Glass Apparatus; Orders for laboratory glass- ware delivered after several years or not at all. Particularly funnels ar unobtainable. Glycerine; Though liable to restrictions, available in modest quantities. Iodine; Compounds very scarce. Iron Ammonium Citrate; Almost unobtainable. Manganese sulphate; Not available. Papalne; Unobtainable. Papavarine; Delivered only once. Peanut Oil; Completely exhausted. Phenacetln; Unobtainable. Potassium Permanganate; Not available. Haney metal; After the bombing of the fac- tory, unobtainable. Sodium Benzoate; Supplied In small Quantities. Sodium Fluoride; Not available. Sulphuric Acid; Decreasing delivery. Semlcarbazlde; We have the impression that the last stocks sire exhausted. Tartaric Acid; Unobtainable. Trlchloro-acetic Acid; Not available. All fine chemicals for analytical purposes were very difficult to. obtain, or were not delivered at all. Iodine; Papaine;